Jessica Eisenstatt

Jessica Eisenstatt, PhD is a CMC Regulatory Affairs Associate Director at AstraZeneca supporting global submissions of biologics, including cell therapy products. Prior to her role at AstraZeneca, Jessica served as an Interagency Oncology Taskforce Fellow at the FDA, overseeing product quality reviews and performing regulatory research focused on the safety and effectiveness of cell and tissue therapy-based biologics. Jessica received her Bachelor of Science in Biochemistry from Syracuse University and her PhD in Biochemistry at Case Western Reserve University. She served as a Postdoctoral Fellow in the Genetics Branch at the National Cancer Institute, National Institutes of Health. Her research in both roles focused on the regulation of genome maintenance by chromatin modifications. Through a career marked by rigorous scientific inquiry and strategic leadership in regulatory environments, Jessica continues to support the development of novel therapies aimed at improving patient outcomes globally.